Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR

Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR

Bibliographic Details
Main Authors:	Theresa L Walunas, Lisa H Butterfield, William J Murphy, Elizabeth M Jaffee, Bart O Roep, Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Christian A Koch, Arlene H Sharpe
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-09-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/9/e002627.full

Similar Items

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors
by: Harriet Kluger, et al.
Published: (2023-03-01)

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
by: James L. Gulley, et al.
Published: (2017-07-01)

Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
by: Samantha L. Bucktrout, et al.
Published: (2018-10-01)

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
by: Jerome Galon, et al.
Published: (2016-11-01)

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
by: Ranee Mehra, et al.
Published: (2023-03-01)

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
by: James L Gulley, et al.
Published: (2023-03-01)

The concise AACR2 /
by: Gorman, Michael, 1941-
Published: (2004)

AACR2 headings: a five-year projection of their impact on catalogs/
by: 422109 Dowell, Arlene Taylor
Published: (1982)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
by: Rajeev Sharma, et al.
Published: (2021-06-01)

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
by: Jeffrey Sosman, et al.
Published: (2023-07-01)

AACR2: OCLC's Implementation and Database
by: Georgia L. Brown
Published: (1981-09-01)

Addressing racial and ethnic disparities in AACR project GENIE
by: Shawn M. Sweeney, et al.
Published: (2023-08-01)

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
by: Lisa H. Butterfield, et al.
Published: (2018-12-01)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
by: I. Puzanov, et al.
Published: (2017-11-01)

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
by: Laura C Cappelli, et al.
Published: (2023-03-01)

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
by: Balwit James M, et al.
Published: (2010-12-01)

AACR2 decisions and rule interpretations /
by: Howarth, Lynne C., et al.
Published: (1994)

The British Library's Approach to AACR2
by: Lynne Brindley
Published: (1981-09-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
by: Ronald Levy, et al.
Published: (2020-10-01)

"SITC DALAM GERAKAN KESEDARAN BANGSA" /
by: Universiti Pendidikan Sultan Idris
Published: (2012)

Practical cataloguing : AACR, RDA and MARC21 /
by: Welsh, Anne, 1972-, et al.
Published: (2012)

AACR2 : cataloging of graphic and micrographic materials/
by: Rosna Taib, 1947-, et al.

Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
by: Robert Brown, et al.
Published: (2025-01-01)

Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Published: (2023-09-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
by: James L Gulley, et al.
Published: (2024-06-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
by: Raffit Hassan, et al.
Published: (2022-05-01)

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
by: Deborah Collyar, et al.
Published: (2025-03-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Meniti zaman : SITC, MPSI, IPSI UPSI /
by: Abu Bakar Nordin, 1943-, et al.
Published: (2000)

Practical cataloguing : AACR2, RDA and MARC21 /
by: Welsh, Anne, 1972-, et al.
Published: (c201)

Cartographic materials : a manual of interpretation for AACR2
by: Parker, Velma, et al.
Published: (1982)

An introduction to AACR2 (Anglo - American Cataloguing Rules)/
by: 333316 Krishnan Kumar
Published: (1986)

Revolutions of change in descriptive cataloging: from AACR to RDA
by: Hesham Makki
Published: (2009-09-01)

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
by: Disis Mary L, et al.
Published: (2011-09-01)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
Published: (2021-01-01)

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
by: John Barrett, et al.
Published: (2020-10-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
by: Amaia Lujambio, et al.
Published: (2021-09-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
by: Gary D Steinberg, et al.
Published: (2021-07-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
by: Lipika Goyal, et al.
Published: (2023-06-01)